Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · May 14, 2023

Effect of Dapagliflozin on Total Heart Failure Events in Patients With HFmrEF or HFpEF

JAMA Cardiology


Additional Info

Disclosure statements are available on the authors' profiles:

JAMA Cardiology
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Trial
JAMA Cardiol 2023 Apr 26;[EPub Ahead of Print], PS Jhund, BL Claggett, A Talebi, JH Butt, SB Gasparyan, LJ Wei, ZR McCaw, U Wilderäng, O Bengtsson, AS Desai, M Petersson, AM Langkilde, RA de Boer, AF Hernandez, SE Inzucchi, MN Kosiborod, CSP Lam, FA Martinez, SJ Shah, M Vaduganathan, SD Solomon, JJV McMurray

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading